Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 442 | 2020 |
Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor β2 (IL-12Rβ2), IL-7R, and stromal FoxP3/CD3 ratio are independent … K Suzuki, K Kadota, CS Sima, J Nitadori, VW Rusch, WD Travis, ... Journal of clinical oncology 31 (4), 490, 2013 | 202 | 2013 |
Prognostic immune markers in non–small cell lung cancer K Suzuki, SS Kachala, K Kadota, R Shen, Q Mo, DG Beer, VW Rusch, ... Clinical Cancer Research 17 (16), 5247-5256, 2011 | 190 | 2011 |
A proteogenomic portrait of lung squamous cell carcinoma S Satpathy, K Krug, PMJ Beltran, SR Savage, F Petralia, C Kumar-Sinha, ... Cell 184 (16), 4348-4371. e40, 2021 | 183 | 2021 |
A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma K Kadota, K Suzuki, SS Kachala, EC Zabor, CS Sima, AL Moreira, ... Modern pathology 25 (8), 1117-1127, 2012 | 174 | 2012 |
A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma K Kadota, K Suzuki, C Colovos, CS Sima, VW Rusch, WD Travis, ... Modern Pathology 25 (2), 260-271, 2012 | 168 | 2012 |
Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma SS Kachala, AJ Bograd, J Villena-Vargas, K Suzuki, EL Servais, K Kadota, ... Clinical cancer research 20 (4), 1020-1028, 2014 | 160 | 2014 |
Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma K Kadota, K Suzuki, CS Sima, VW Rusch, PS Adusumilli, WD Travis Journal of Thoracic Oncology 6 (5), 896-904, 2011 | 147 | 2011 |
Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters K Suzuki, EL Servais, NP Rizk, SB Solomon, CS Sima, BJ Park, ... Journal of Thoracic Oncology 6 (4), 762-767, 2011 | 129 | 2011 |
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma K Kadota, C Colovos, K Suzuki, NP Rizk, MPS Dunphy, EC Zabor, ... Annals of surgical oncology 19, 3598-3605, 2012 | 106 | 2012 |
Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients K Suzuki, K Kadota, CS Sima, M Sadelain, VW Rusch, WD Travis, ... Cancer immunology, immunotherapy 60, 1721-1728, 2011 | 86 | 2011 |
Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma AJ Bograd, K Suzuki, E Vertes, C Colovos, EA Morales, M Sadelain, ... Cancer Immunology, Immunotherapy 60, 1509-1527, 2011 | 73 | 2011 |
Tube cholecystostomy before cholecystectomy for the treatment of acute cholecystitis K Suzuki, M Bower, S Cassaro, RI Patel, MS Karpeh, IM Leitman JSLS: Journal of the Society of Laparoendoscopic Surgeons 19 (1), 2015 | 38 | 2015 |
Bronchoscopy simulation training as a tool in medical school education M Gopal, AA Skobodzinski, HM Sterbling, SR Rao, C LaChapelle, ... The Annals of thoracic surgery 106 (1), 280-286, 2018 | 37 | 2018 |
Age, race, and income are associated with lower screening rates at a safety net hospital K Steiling, T Loui, S Asokan, S Nims, P Moreira, A Rebello, VR Litle, ... The annals of thoracic surgery 109 (5), 1544-1550, 2020 | 36 | 2020 |
High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology K Kadota, SS Kachala, J Nitadori, K Suzuki, MPS Dunphy, CS Sima, ... Journal of Thoracic Oncology 7 (7), 1192-1197, 2012 | 34 | 2012 |
The impact of residential racial segregation on non-small cell lung cancer treatment and outcomes CA Annesi, MR Poulson, KS Mak, U Tapan, TA Dechert, VR Litle, ... The Annals of Thoracic Surgery 113 (4), 1291-1298, 2022 | 27 | 2022 |
Resection of primary and secondary tumors of the sternum: an analysis of prognostic variables U Ahmad, H Yang, C Sima, DH Buitrago, RT Ripley, K Suzuki, MS Bains, ... The Annals of thoracic surgery 100 (1), 215-222, 2015 | 25 | 2015 |
An in vivo platform for tumor biomarker assessment EL Servais, K Suzuki, C Colovos, L Rodriguez, C Sima, M Fleisher, ... PloS one 6 (10), e26722, 2011 | 25 | 2011 |
Redlining, structural racism, and lung cancer screening disparities MR Poulson, KM Kenzik, S Singh, F Pavesi, K Steiling, VR Litle, K Suzuki The Journal of Thoracic and Cardiovascular Surgery 163 (6), 1920-1930. e2, 2022 | 23 | 2022 |